Celldex Therapeutics buy Cantor Fitzgerald
Start price
16.08.23
/
50%
€27.80
Target price
16.08.24
€49.46
Performance (%)
20.86%
Price
23.05.24
€33.60
Summary
This prediction is currently active. The prediction currently has a performance of 20.86%. This prediction currently runs until 16.08.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | -9.189% | -9.189% |
iShares Core DAX® | -0.654% | 1.989% |
iShares Nasdaq 100 | 0.903% | 5.664% |
iShares Nikkei 225® | -0.740% | -1.363% |
iShares S&P 500 | -0.013% | 3.020% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $54.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€38.80
22.03.24
22.03.24
€61.99
22.03.25
22.03.25
-13.40%
23.05.24
23.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.80
03.11.23
03.11.23
€48.43
03.11.24
03.11.24
41.18%
23.05.24
23.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.00
12.10.23
12.10.23
€51.15
12.10.24
12.10.24
39.20%
23.05.24
23.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.80
27.09.23
27.09.23
€51.25
27.09.24
27.09.24
34.88%
23.05.24
23.05.24